16:45-17:00
Christian Kupatt, Technische Universität München, Michael Ott, Hannover Medical School
Optimizing genetic payload and modeling systems– current status in a nutshell
INV04 17:00-17:45
Luigi Naldini, SR Tiget, Milan ⓘ
Hematopoietic stem cell gene therapy: how to choose the best tools and broaden its therapeutic scope
INV05 17:45-18:15
Alberto Auricchio, Tigem Naples ⓘ
Expanding AAV transfer capacity on the retina
INV06 18:15-18:45
Cornelia Lee-Thedieck, Leibniz University Hannover ⓘ
In vitro models of the hematopoietic stem cell niche: from fundamental research to application as test systems
OR03 18:45-19:00
Reto Eggenschwiler, Hannover Medical School
PB-PE, a piggyBac prime editing platform for efficient evaluation of optimal CRISPR-PE designs
OR04 19:00-19:15
Dawid Glow, University Medical Center Hamburg-Eppendorf
CRISPR-to-Kill (C2K) - development of a versatile method that utilizes the bacterial immune system to kill cancer cells

